JENBURKT PHARMACEUTICALS
|
The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 2.41.
| Share Price | ₹925.0 | Oct 12,2026 |
| Market Cap | ₹407.0 Cr | |
| Sales-TTM | ₹168.7 Cr | TTM-Standalone Results |
| Price/Sales | 2.41x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹407.0 Cr] as on Oct 12,2026
(/) Sales [ ₹168.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.41x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '2.41 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS
PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.37x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.94x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 2.1x.
How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| JENBURKT PHARMACEUTICALS | 168.7 | 2.41 | 407.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.04 | 422,067.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.17 | 248,983.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.32 | 177,974.0 |
| CIPLA LTD | 28,324.4 | 3.75 | 106,130.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.09 | 102,707.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.72 | 99,089.5 |
| LUPIN LTD | 29,966.6 | 2.97 | 88,988.6 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.97 | 113,616.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.80 | 97,972.5 |
| LAURUS LABS LTD | 7,269.6 | 15.39 | 111,899.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.41x |
| Max industry PS | 22.17x |
| Median industry PS | 3.97x |
| Average industry PS | 7.42x |
You may also like the below Video Courses